HER2/Neu Positive

18 clinical trials · Condition

Record	Firm	Date
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity (NCT03418961)	SWOG Cancer Research Network	2017-11-01
Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis (NCT02774681)	Northwestern University	2016-08-31
Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab (NCT00194714)	University of Washington	2016-05-01
Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients (NCT02152943)	M.D. Anderson Cancer Center	2014-07-17
Trastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by Surgery (NCT01816035)	University of Washington	2014-06-01
Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy (NCT01922921)	University of Washington	2014-02-05
Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast Cancer (NCT01846091)	Mayo Clinic	2013-04-09
Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer (NCT01750073)	University of Nebraska	2012-12-07
Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab Only (NCT01434303)	National Cancer Institute (NCI)	2012-01-10
Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer (NCT01273610)	City of Hope Medical Center	2011-04-20
MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer (NCT01319539)	National Cancer Institute (NCI)	2011-04-01
Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer (NCT01327781)	National Cancer Institute (NCI)	2011-03-25
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer (NCT01275677)	National Cancer Institute (NCI)	2011-02-08
RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer (NCT01217411)	National Cancer Institute (NCI)	2010-10-01
Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ (NCT00555152)	National Cancer Institute (NCI)	2009-08-19
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer (NCT00785291)	National Cancer Institute (NCI)	2008-10-13
Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery (NCT00513292)	National Cancer Institute (NCI)	2007-07-01

Track HER2/Neu Positive automatically

Every clearance here is in the API, with alerts when new ones post.